medigraphic.com

2015, Number 1

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2015; 16 (1)

Treatment and outcome of patients with diabetic foot ulcers

Díaz SL, Iser RD, Pérez FD, Díaz SR, Palacio VY

Language: Spanish
References: 14
Page: 29-36
PDF size: 110.81 Kb.


ABSTRACT

Introduction: diabetes mellitus is a chronic and complex metabolic disease characterized by absolute or relative insulin deficiency. The diabetic foot is associated with neurological abnormalities and peripheral vascular disease of varying severity in the lower extremities.
Objective: to describe the treatment and outcome of patients with diabetic foot ulcers.
Methods: a descriptive study in a sample of 51 patients treated at the clinic III "René Vallejo Ortiz", municipality Manzanillo, during the 2012 data on age, sex, type of diabetes, degree of injury were taken as classified Wagner, type treatment and outcome of patients with diabetic foot ulcers.
Results: the sample was characterized by a predominance of type 2 diabetes in male patients in the age groups between 54 and 65 and 65 and over. The lesions type I and II of Wagner prevailed in the younger age groups. The treatment applied was the local priest combined with topical or oral antibiotics in 40 (78.4 %) patients and intralesional Heberprot-P in 11 (21, 5 %). 96.1 % had a satisfactory outcome.
Conclusions: the successful development of a high percentage of patients indicates that the applied treatments combined Heberprot-P and healing, are suitable for diabetic foot ulcers in patients in the sample.


REFERENCES

  1. Stess RM, Jensen SR, Mirmiran R. The role of dynamic plantar pressures in diabetic foot ulcers. Diabetes Care. 1997;20(5):855-8.

  2. Camejo M, García A, Rodríguez E, Carrizales ME, Chique J. Visión epidemiológica de la diabetes mellitus: Situación en Venezuela. Registro epidemiológico y propuesta de registro. Programas de detección precoz. Rev Venez Endocrinol Metab. 2012 [citado 28 Mar 2014];10(supl1):2-6. Disponible en: http://www.scielo.org.ve/scielo.php?script=sci_arttext&pid=S1690- 31102012000400002&lng=es

  3. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24.

  4. American Diabetes Association. Arteriopatía periférica en pacientes con diabetes. Diabetes Care. 2003;26(12):3333-41.

  5. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-81.

  6. Blanes Mompó JI, Al-Raies Bolaños B, Fernández González S. Factores de riesgo en el pie diabético. Angiología. 2012 [citado 7 Feb 2014];64 (Esp Cong):58-62. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90136971&pident_ usuario=0&pcontactid=&pident_revista=294&ty=135&accion=L&origen=zonadelectura& web=zl.elsevier.es&lan=es&fichero=294v64nEsp.Congresoa90136971pdf001.pdf

  7. Jelinek JE. The skin in diabetes. Diabetic Med. 1993 [citado 7 Feb 2014];10:201- 13. Disponible en: http://onlinelibrary.wiley.com/doi/10.1111/j.1464- 5491.1993.tb00048.x/references

  8. López-Antuñano S, López-Antuñano FJ. Diabetes mellitus y lesiones del pie. Salud pública Méx. 1998 [citado 2 Feb 2014];40(3):281-92. Disponible en: http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036- 36341998000300010&lng=en

  9. García Herrera A, Rodríguez Fernández R, Peña Ruiz V, Rodríguez Hernández L, Acosta Cabadilla L, Febles Sanabria R, et al. El significado clínico del pie diabético en un análisis de diez años. Rev Cubana Angiol Cir Vasc. 2011 [citado 2 Feb 2014];12(1). Disponible en: http://www.bvs.sld.cu/revistas/ang/vol12_01_11/ang08111.htm

  10. Ferrer del Castillo. Pie diabético y su prevención. Mediciego. 2006 [citado 7 Mar 2014];12 suppl 1. Disponible en: http://bvs.sld.cu/revistas/mciego/vol12_supl1_06/revisiones/r7_v12_supl106.html

  11. Gallardo Pérez U, Zangronis Ruano L, Hernández Piñero L. Perfil epidemiológico del pie diabético. Rev Cubana Angiol Cir Vasc. 2004 [citado 2 Feb 2014];5(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol5_1_04/ang16104.htm

  12. Lipsky BA , Berendt AR,Cornia PB,Pile JC,Peters EJ, Armstrong DG, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012 [cited 2014 Jan 13];54(12):e132-73. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/22619242

  13. Junco Gelpi DA, Moncada JO, Montoya Cardero LE, Blanco Trujillo F, Hernández González JC. Eficacia del Heberprot-P® en el tratamiento de las úlceras del pie diabético. MEDISAN 2012 [citado 12 Abr 2014];16(11):1707-11. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029- 30192012001100007&lng=es

  14. Hernández Cañete CM, González Pacheco HH, Sánchez Montiel ME, Vega García R. Tratamiento con Heberprot-P en la provincia Ciego de Ávila. Rev Cubana Angiol Cir Vasc. 2009 [citado 13 Feb 2014];10(1):12-21. Disponible en: http://bvs.sld.cu/revistas/ang/vol10_1_09/ang03109.htm




2020     |     www.medigraphic.com